You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IK-175

Showing 1 - 25 of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +5 more
  • IK-175 + nivolumab
  • Chicago, Illinois
  • +3 more
Jul 26, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • IK-175
  • IK-175 and nivolumab
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Keratitis Trial in Damieta (Amniotic membrane transplantation)

Completed
  • Keratitis
  • Amniotic membrane transplantation
  • Damieta, New Damietta, Egypt
    Ehab tharwat
Oct 1, 2023

Acute Myocardial Infarction, CHF, ST-Elevation Myocardial Infarction Trial in Worldwide (IK-5001, Saline Solution)

Completed
  • Acute Myocardial Infarction
  • +2 more
  • IK-5001
  • Saline Solution
  • Birmingham, Alabama
  • +81 more
Aug 9, 2022

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Fasting, Perioperative Pulmonary Aspiration Trial in Hjørring (Ice water)

Completed
  • Fasting
  • Perioperative Pulmonary Aspiration
  • Ice water
  • Hjørring, North Denmark, Denmark
    Department of Anaestesia
Jan 5, 2023

Postpartum Trial in Batman (skin-to-skin contact)

Completed
  • Postpartum
  • skin-to-skin contact
  • Batman, Turkey
    Hatice OKÇU
Mar 26, 2023

Pain, Postoperative Trial in Almagro (Gabapentin, Placebo)

Completed
  • Pain, Postoperative
  • Almagro, Buenos Aires, Argentina
    Sofía Konekny
Dec 2, 2022

Healthy Volunteers Bioavailability Study Trial in Xuzhou (Revefenacin Inhalation Solution)

Completed
  • Healthy Volunteers Bioavailability Study
  • Revefenacin Inhalation Solution
  • Xuzhou, China
    Xuzhou Central Hospital
Mar 21, 2022

Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

Recruiting
  • Carcinoma, Ovarian Epithelial
  • Low Grade Serous Adenocarcinoma of Ovary
  • Letrozole tablets
  • carboplatin AUC 5 and paclitaxel 175 mg/m2
  • Brescia, BS, Italy
  • +1 more
Oct 26, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +90 more
Dec 19, 2022

COPD Trial in China (Revefenacin 175 mcg in 3 ML Inhalation Solution, Placebo inhalation solution QD)

Recruiting
  • COPD
  • Revefenacin 175 mcg in 3 ML Inhalation Solution
  • Placebo inhalation solution QD
  • Beijing, Beijing, China
  • +2 more
Feb 22, 2022

Chemo-induced Peripheral Neuropathy Trial in Goshen, Ogden (WST-057 Active, Placebo)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • WST-057 Active
  • Placebo
  • Goshen, Indiana
  • +1 more
Aug 3, 2022

SHARE Project Define

Recruiting
  • HIV
    • Tallahassee, Florida
      Florida State University, Center for Translational Behavioral Sc
    Nov 6, 2023

    Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

    Not yet recruiting
    • Stage III Ovarian Cancer
    • +5 more
    • (no location specified)
    Dec 12, 2022

    Well-being Trial in Amsterdam (LifeHack, LifeHack-C)

    Recruiting
    • Well-being
    • LifeHack
    • LifeHack-C
    • Amsterdam, Netherlands
      Vrije Universiteit Amsterdam
    Oct 24, 2022

    Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen Memorial Hospital
    Nov 11, 2022

    Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

    Not yet recruiting
    • Untreated Advanced or Recurrent Thymic Carcinomas
    • Chuo, Tokyo, Japan
      National Cancer Center Hospital
    Apr 16, 2023

    IBS - Irritable Bowel Syndrome, Diarrhea Trial in Shanghai, Chengdu (QiMeiYan Probiotics, Placebo product)

    Not yet recruiting
    • IBS - Irritable Bowel Syndrome
    • Diarrhea
    • QiMeiYan Probiotics
    • Placebo product
    • Shanghai, Shanghai, China
    • +1 more
    Jun 2, 2023

    Preoperative Insomnia and Postoperative Quality of Recovery : A

    Recruiting
    • Sleep Disorder
      • Guangzhou, Guangdong, China
        the Sixth Affiliated Hospital, Sun Yat-sen University
      Aug 21, 2023

      EZETROL® Re-examination Study (MK0653-175)(COMPLETED)

      Completed
      Has Results
      • Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022

        Smoking, Alcoholism Trial in Newington (Cognitive Behavior Therapy for alcohol and smoking cessation, Nicoderm CQ nicotine

        Completed
        Has Results
        • Smoking
        • Alcoholism
        • Cognitive Behavior Therapy for alcohol and smoking cessation
        • +3 more
        • Newington, Connecticut
          VA Connecticut Healthcare System
        Aug 11, 2021

        Child Development Trial in Boston, Longacres (ECD intervention for CHEUs, Usual care for CHEUs)

        Enrolling by invitation
        • Child Development
        • ECD intervention for CHEUs
        • Usual care for CHEUs
        • Boston, Massachusetts
        • +1 more
        May 2, 2022

        KCNJ11-related Intermediate Developmental Delay, Epilepsy and

        Recruiting
        • Neurodevelopmental Disorders
        • +5 more
        • Chicago, Illinois
        • +3 more
        Feb 20, 2023